Mendeleev Commun., 2012, 22, 125–126
(CSA) led to intense hydrolysis of the silane protective group in
Online Supplementary Materials
the case of 2a, whereas pyridinium-p-toluenesulfonate (PPTS)
was not effective.
Supplementary data associated with this article can be found
in the online version at doi:10.1016/j.mencom.2012.05.002.
Diastereomeric products 4a–c and 5a–c were formed in the
reaction in nearly equal quantities in 56–77% overall yields.†
Epimerization of chiral centre in reagent 3 occurred to a negligible
extent only in the case of 2c, when anomeric product 6c was
isolated (although in insignificant amounts) along with the major
products 4c and 5c. The configuration of 6c follows from the
doublet (J 4.2 Hz) character of the anomeric H-2' signal in the
1H NMR spectrum, whereas compounds 4 and 5 display the cor-
responding signal as a singlet.
Diastereomeric pairs of 4a–c and 5a–c differed significantly
in their mobility during chromatography on silica gel (DRf =
= 0.04–0.10) and could be easily thus separated. The regenera-
tion of (–)-2a–c and their corresponding (+)-enantiomers from
the individual diastereomers 4a–c and 5a–c was achieved by short
heating with a catalytic amount of PPTS in MeOH (Scheme 2).
The chiral auxiliary 3 was recovered in 50% yield along with
dimer 7 (~5–7%) and methyl derivative 8 (~25%) (cf. ref. 18).
Compounds 7 and 8 can be transformed into lactol 3 by acidic
hydrolysis.
References
1 (a) S. Das, S. Chandrasekhar, J. S. Yadav and R. Grée, Chem. Rev.,
2007, 107, 3286; (b) P. W. Collins and S. W. Djuric, Chem. Rev., 1993, 93,
1533; (c) N.A. Sheddan, M. Czybowski and J. Mulzer, Chem. Commun.,
2007, 2107.
2 (a) E. J. Corey, T. K. Schaaf, W. Huber, U. Koelliker and N. M. Weinshenker
J. Am. Chem. Soc., 1970, 92, 397; (b) E. J. Corey, S. M.Albanico, U. Koelliker
,
,
T. K. Schaaf and R. K. Varma, J. Am. Chem. Soc., 1971, 93, 1491; (c) E. J.
Corey and H. E. Ensley, J. Am. Chem. Soc., 1975, 97, 6908; (d) J. G.
Martynow, J. Józ´wik, W. Szelejewski, O. Achmatowicz, A. Kutner,
K. Wis´niewski, J. Winiarski, O. Zegrocka-Stendel and P. Gołe˛biewski,
Eur. J. Org. Chem., 2007, 689; (e) M. Terinek, V. Kozmik and J. Palecˇek,
Collect. Czech. Chem. Commun., 1997, 62, 1325; (f) G. A. Tolstikov,
M. S. Miftakhov, M. E. Adler, N. G. Komissarova, O. M. Kuznetsov and
N. S. Vostrikov, Synthesis, 1989, 940.
3 (a) Aldrich, Catalog Handbook of Fine Chemicals, 1996–1997, p. 786;
(b) Pharma Tech International, Inc., 21 Just Road, Fairfield, N7 07004,
USA.
4 (a) J. S. Bindra, A. Grodski, T. K. Schaaf and E. J. Corey, J. Am. Chem.
Soc., 1973, 95, 7522 and references cited therein; (b) N. R. A. Beeley,
R. Peel, J. K. Sutherland, J. J. Holohan, K. B. Mallion and G. J. Sependa,
Tetrahedron, 1981, 37, Suppl. (9), no. 1, 441; (c) E. J. Corey and B. B.
Snider, J. Org. Chem., 1974, 39, 256.
5 (a) I. Tömösközi, L. Gruber, C. Kovács, I. Szekely and V. Simonides,
Tetrahedron Lett., 1976, 50, 4639; (b) G. A. Tolstikov, M. S. Miftakhov,
F. A. Valeev, N. S. Vostrikov and R. R. Akhmetvaleev, Zh. Org. Khim.,
1984, 20, 221 (in Russian).
6 (a) E. J. Corey, Z. Arnold and J. Hutton, Tetrahedron Lett., 1970, 92,
307; (b) P. A. Grieco and J. J. Reap, J. Org. Chem., 1973, 38, 3413.
7 (a) K. Petzoldt, H. Dahl, W. Skuballa and M. Gottwald, Liebigs Ann.
Chem., 1990, 1087; (b) T. Sugahara, I. Satoh, O.Yamada and S. Takano,
Chem. Pharm. Bull., 1991, 39, 2758; (c) D. Bakshi, V. K. Mahindroo,
R. Soman and S. Dev, Tetrahedron, 1989, 45, 767.
O
O
O
O
O
O
O
MeOH, heat
PPTS
4a–c
+
H
H
H
H
OR
O
HO
(–)-2a–c
7, ~5–7%
O
HO
MeO
O
O
+
+
H
H
H
H
8 (a) E. J. Corey and J. Mann, J. Am. Chem. Soc., 1973, 95, 6832; (b) C. Bolm
and O. Beckmann, Chirality, 2000, 12, 523; (c) M. P. Doyle and A. J.
Catino, Tetrahedron Asymmetry, 2003, 14, 925; (d) C. J. Wallis, Eur.
Patent 74856, Glaxo, 1983 (Chem. Abstr., 1984, 99, 139627).
9 (a) B. Žak, I. Veselý, K. Neumitka and J. Palecˇek, Collect. Czech. Chem.
Commun., 1991, 56, 1690; (b) A. Romano, D. Romano, F. Molinari,
R. Gandolfi and F. Costantino, Tetrahedron Asymmetry, 2005, 16, 3279;
(c) X.-Ch. He and Ch.-Y. Qi, Chin. J. Chem., 2007, 25, 583.
10 A. K. Mandal, D. P. Borude, R.Armugasamy, N. R. Soni, D. C. Jawalkar,
S. W. Mahajan, K. R. Ratnam and A. D. Goghare, Tetrahedron, 1986,
42, 5715.
8, ~25%
3, ~50%
O
O
MeOH, heat
PPTS
+
8
3
+
+
7
5a–c
~50%
~5–7%
~25%
OR
HO
11 P. J. Kocien´ski, Protecting Groups, Thieme, Stuttgart, 1994, p. 260.
(+)-2a–c
12 O
. S. Kukovinets,V. G. Kasradze, F. Z. Galin, L.V. Spirikhin, R.A. Zainullin
,
(–)-2a, 68% (>98% ee) (+)-2a, 64% (>98% ee)
(–)-2b, 70% (>97% ee) (+)-2b, 71% (>97% ee)
(–)-2c, 85% (>96% ee) (+)-2c, 86% (>96% ee)
M. I. Kislitsyn, M. I. Abdullin, R. V. Kunakova and G. A. Tolstikov, Zh.
Org. Khim., 2002, 38, 536 (Russ. J. Org. Chem., 2002, 38, 511).
13 J. J. Martel, J. P. Demote, A. P. Tech and J. R. Tessier, Pestic. Sci., 1980,
11, 118.
Scheme 2
14 M. Suzuki, T. Kawagishi, T. Suzuki and R. Noyori, Tetrahedron Lett.,
1982, 23, 4057.
In summary, we have elaborated a three-step protocol that
produces enantiomers of the Corey lactone derivatives 2a–c from
racemic lactone ( )-1 in overall yields 20–25%. This protocol
provides an additional example of the hemiacylal 3 [(–)-3 or (+)-3]
efficacy as a reagent for the resolution of racemic alcohols, in
addition to the published resolutions of alletrolone,13 4-hydroxy-
2-cyclopenten-1-one,14 lineatine,15 2-allyl-4-hydroxycyclo-
pentenone16 etc.17 Taking into consideration the importance and
prevalence of the Corey strategy in the prostaglandin synthesis, we
hope the protocol described above could find an application in
the chemistry of prostaglandins and other cyclopentanoids as well.
15 K. Mori, T. Uematsu, M. Minobe and K. Vanagi, Tetrahedron, 1983, 39,
1735.
16 Jpn. Kokai Tokkyo Koho, Jpn. Patent 58041836, Teijin (Chem. Abstr.,
1983, 99, 122166y).
17 J. Salaün, Chem. Rev., 1989, 89, 1247.
Received: 28th December 2011; Com. 11/3856
– 126 –